Business
US biotech Novavax could make COVID vaccine onshore in Australia – Sydney Morning Herald
The company behind Australia’s third major coronavirus vaccine candidate says it would be happy to set up shop in Australia, just like its competitor Moderna.
American biotechnology company Novavax has outlined plans to make doses of its coronavirus vaccine in Australia after revealing it is searching for a manufacturing partner to produce its protein-based jab onshore.
The federal government has ordered 51 million doses of Novavaxs product, which is still awaiting regulatory clearances in the US and Australia. In an interview with The Sydney Morning Herald and The Age, Novavaxs chief commercial officer John Trizzino said the company has had early conversations…
-
General18 hours agoCoalition seeks to rebuild ties with Indian community
-
Noosa News20 hours agoOver $50K raised for Noosa’s Oz Bayldon after brain aneurysm
-
Business17 hours agoHow to retire in your 50s with ASX shares
-
Noosa News19 hours agoNational Drought Forum convenes in SA to put policy under scrutiny